Practical HPLC in Pharmaceutical Analysis
| Type |
Course |
| Language |
English |
| Date |
April 9, 2008
from
08:30 am
to
05:00 pm
|
| Venue |
Doubletree New Orleans
300 Canal St
New Orleans,
LA
70130
US
|
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
ACS
1155 Sixteenth Street, NW
Washington, DC ,
20036
US
1-800-227-5558 ext. 4508
202-872-6336
service@acs.org
|
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
Analytical procedures are used to assure that the drug product meets applicable standards of identity, strength, quality and purity during its expiration dating. The majority of analytical methods used in pharmaceutical development are HPLC analyses. cGMPs require stability indicating methods to monitor the drug product’s stability profiles. Therefore, method development and validation significantly impact the drug development process. Additional expectations are also placed on the monitoring of impurities and degradation products.
This course focuses on reversed-phase analysis of drug substances and drug products (small molecule). It will discuss forced degradation strategies to develop stability-indicating analytical procedures. A review of ICH guidelines on validation and impurities will be done to help Pharmaceutical Manufacturers to gain better understanding of method validation by phases of drug development and regulatory expectations through a review of warning letters.
Registrants will receive a copy of Modern HPLC for Practicing Scientists, by Dong (Wiley-Interscience, 2006) with their registration.
Key Topics
* Design your forced degradation studies to support method specificity
* Review cGMP regulations that govern the pharmaceutical laboratory.
* Understand ICH regulations surrounding method validation and stability-indicating procedures (Q2A&B)
* Impact of developing stability indicating methods
* Understand Q3 for impurities monitoring
Speakers
Kim Huynh-Ba is the Technical Director of Pharmalytik Consulting and Training Services (www.pharmalytik.com). With over twenty years of experience in various analytical areas of pharmaceutical development and a primary focus in stability sciences, she specializes in analytical development, stability, outsourcing and technology transfer management. She has been involved with several projects harmonizing and optimizing analytical best practices in several companies, including those under Consent Decree.
Kim has authored numerous technical publications and is invited as a frequent speaker at national and international conferences. Since 2001, she has conducted training activities on cGMP compliance and quality issues for national organizations such as ACS, AAPS, IIR, SWE, IVT and CBI. She is also the founder of the AAPS Stability Focus Group, and is an active member of AAPS, PSDG, as well as serving on the Governing Board of Eastern Analytical Symposium (EAS). She also is EAS 2008 Short Course Chair and AAPS 2008 APQ Distance Learning Chair.
Cost
Member - $895.00
Academic Member - $447.50
Note: This discount is only available if you register by fax, mail or phone and mention this discount and may not be combined with any other offer.
Nonmember - $995.00
Early Registration - Register before March 3, 2008 for the ACS Spring National Meeting Short Courses and receive $100 off the standard member/nonmember fees.
Late Registration - Registrations after March 31, 2008 for the ACS Spring National Meeting Short Courses will be assessed a $100 administrative fee.
Group Rate - Five for Four! Register five people for one course, one person for five courses, or any combination in between and your fifth registration is free.
Note: This discount is only available if you register by fax, mail or phone and mention this discount and may not be combined with any other offer.
More information about this event…